The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium TransientsChristopher Schneider, Peter P. Rainer|Scientific Reports|2018Cited by 32